Singapore markets closed
Straits Times Index
3,285.97 -7.16 (-0.22%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
64,123.81 -2,329.17 (-3.50%) CMC Crypto 200
1,361.07 -21.51 (-1.56%)
GILD Jan 2025 92.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:54PM EDT. Market open.
| Previous close | 12.70 |
| Open | 12.70 |
| Bid | 17.40 |
| Ask | 19.05 |
| Strike | 92.50 |
| Expiry date | 2025-01-17 |
| Day's range | 12.70 - 12.70 |
| Contract range | N/A |
| Volume | |
| Open interest | 63 |
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
© 2024 Yahoo. All rights reserved.